Recent Updates
Recently added Catalysts

Enhabit, Inc.

EHABFDA catalysts, PDUFA dates & pipeline intelligence
$13.8
▲ +0.01 · +0.07%

Last traded May 14, 2026. This price is not current.

Financials

Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Quarterly Cash
Unlock full EHAB financials and dilution scoring
Quarter by quarter figures, cash trend and dilution risk.
Institutional-grade data · Cancel anytime
52W LOW $6.4752W HIGH $14.22
Volume
1.38 M
Value Traded
19.08 M
Short % Float
0.29%
Days to Cover
1.0

Cash Data

Unlock EHAB cash and runway
  • Monthly Burn
  • Burn Trend
  • Dilution Risk
  • SEC Filing

Key Stats

Market Cap
709.11 M
EPS (TTM)
-0.09
P/E Ratio
-156.90
Ent. Value
1.19 B
Total Shares
50.61 M
Float Shares
49.04 M
Insiders
13.14%
Institutions
78.92%

Upcoming Catalysts

FDA decisions, readouts and PDUFA dates · scored by probability of approval

Catalyst Drug / Treatment Stage Prob. of Approval Description Drug Type Therapeutic Area Source
Unlock every EHAB catalyst date and PoA score
Every FDA decision, readout and PDUFA date, with drug type, therapeutic area and a PoA score you can trade on.
Institutional-grade data · Cancel anytime
PoA blends historical approval base rates, trial design score and FDA review track record.

EHAB Catalyst Timeline

Dated clinical, regulatory and corporate events for Enhabit, Inc.

Unlock the full EHAB catalyst timeline
Every PDUFA date, readout, approval and corporate move, tiered by market impact and updated daily.
Institutional-grade data · Cancel anytime

Past FDA Catalysts and PDUFA Decisions

How EHAB actually traded into and out of each decision

Date Drug Catalyst Stage Reaction Event Move % Best Trade %
No matching catalysts
Unlock all EHAB historical catalysts
Institutional-grade data · Cancel anytime
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision

Drug Pipeline Intelligence

No drug pipeline

Enhabit, Inc. is a services and tools company (CRO, lab tools or healthcare services). The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.

Clinical Trial Results

Readouts, endpoints and source filings for every EHAB program

Drug Name Indication Phase Date Trial Results SummaryTitleSource
Scroll for more · summaries link to the source press release
Unlock every EHAB trial readout
Institutional-grade data · Cancel anytime

Inside Trades

Unlock EHAB insider buying and selling
Monthly insider buys and sells against the stock price, with the insider sentiment reading.
Institutional-grade data · Cancel anytime
InsiderSideSharesPriceValueDate
Rush Gregory SDirectorGrant/Award 1,787 80,338 held$13.99 04/10/2026
Unlock the full EHAB insider trade log
Institutional-grade data · Cancel anytime

Hedge Fund 13F Activity

Fund % of Portfolio Current MV Shares Owned Activity
IRON TRIANGLE PARTNERS LP 1.5 % (-6.3 %) 9.91 M 1.03 M -9.83% ( -112.03 K)
Unlock every fund holding EHAB
Every 13F position with quarter over quarter share flow and average entry price.
Institutional-grade data · Cancel anytime
Unlock hedge fund flows in EHAB
Shares held by hedge funds each quarter, and who bought or sold.

Ownership Trends

Sign in to see EHAB ownership
Insider and institutional ownership, quarter by quarter.

EHAB Short Interest

Shares sold short, counted twice a month.

0.29%
Short % of Float
of tradable shares sold short
139.8K
Shares Sold Short
-88.4% vs prior count
1.0 Low
Days to Cover
trading days of normal volume to buy every short share back
1.3M
Avg Daily Volume
the average used for days to cover
Unlock EHAB short interest history
Two years of days to cover and shares sold short, with every count and its change.
Institutional-grade data · Cancel anytime

Options Data

Option Volume

Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg

Option Chain Statistics

ExpiryCall VolPut VolVol P/CCall OIPut OIOI P/CIV CallIV Call OI-WtdIV Call Vol-WtdIV PutIV Put OI-WtdIV Put Vol-Wtd
Unlock EHAB option chain statistics
Per-expiry call and put volume, open interest, put-call ratios and implied volatility.
Institutional-grade data · Cancel anytime

Real-Time Option Chain

CallsStrikePuts
LastVolOILastVolOI
No data available
Unlock the live EHAB option chain
Live calls and puts by strike: last price, volume and open interest for every expiry.
Institutional-grade data · Cancel anytime

Calls vs Puts by Expiry

CallsPutsLog scale
Unlock EHAB options analytics
Institutional-grade data · Cancel anytime

Competitive positioning

How EHAB ranks across every disease it competes in

Competitive Position is a premium feature
See how EHAB ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial

EHAB News

About Enhabit, Inc.

Dallas, TX 10,800 employees ehab.com
Headquarters6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS, TX, 75206
BIOPHARMAWATCH ELITE
Trade the next EHAB catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $24/mo billed annually.
Cancel anytime